Dividends Calendar Earnings Calendar
CBAY

CBAY | Cymabay Therapeutics Inc

Cymabay Therapeutics Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Newark, California, United States

Trade prices

  • Volume:
  • Market Cap: 234.56M
  • Prev closed:
  • Open: 3.04
  • High: 3.2
  • Low: 3.04
  • 52 week low: 2.67
  • 52 week high: 5.13
  • Dividends:No Dividends

Next ER: August 10, 2023 



Top Stories (CBAY)

    Company Profile

    We are a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need. We are evaluating seladelpar in primary biliary cholangitis (PBC). We also have a product program in earlier development that features a unique mechanism of action with potential in chronic diseases.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 7, 2023
    August 10, 2023-0.01 / -0.231M / 11.38MBeat!
    May 15, 2023-0.29 / -0.0934.2M / 28.47MBeat!
    March 16, 2023-0.3 / -0.3- / 5M
    November 14, 2022-0.28 / -0.3- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 7, 2023 12.14 12.34
    12.47
    11.89
    991K -1.62%
    Aug 4, 2023 12.34 12.33
    12.53
    12.18
    854K -0.24%
    Aug 3, 2023 12.37 12.46
    12.53
    12.17
    698K -1.59%
    Aug 2, 2023 12.57 12.8
    12.89
    12.33
    796K -2.56%
    Aug 1, 2023 12.9 13.24
    13.25
    12.68
    1.2M -1.15%
    Jul 31, 2023 13.05 12.5
    13.17
    12.25
    1.9M 6.27%
    Jul 28, 2023 12.28 11.86
    12.5
    11.79
    1.3M 4.78%
    Jul 27, 2023 11.72 11.69
    12.15
    11.5
    1.3M 1.47%
    Jul 26, 2023 11.55 11.79
    11.84
    11.41
    780K -1.62%
    Jul 25, 2023 11.74 11.64
    11.9
    11.4
    1.9M -0.76%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:1988
    • Employees:59

    News

    News for (CBAY)

    This company doesn't provide a dividend.


    Talk about Cymabay Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Aug 10, 2023 (Same day)

    baba six nwsa zyne dds flo cpri usfd azul sbs mux onto 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    TwitterFacebookLinkedIn

    Peers / Similar stocks 

    xlv 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Currency Trading For Dummies
    Buy on Amazon

    Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?